Mrv0541 04111413432D 18 19 0 0 0 0 999 V2000 2.8150 -1.0862 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.0808 -0.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0681 0.0205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8613 0.2481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.3228 -0.4359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2699 -1.1917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.6113 -0.7547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6399 0.0699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.3683 0.4575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3553 1.2726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.1230 -1.1451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8150 -1.9111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5216 -2.3189 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.2368 -1.9058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9311 -2.3065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2370 -1.0692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9364 -0.6655 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.6356 -1.8995 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 1 5 1 0 0 0 0 2 6 1 0 0 0 0 6 7 2 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 3 9 1 0 0 0 0 9 10 2 0 0 0 0 7 11 1 0 0 0 0 1 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 14 16 1 0 0 0 0 16 17 1 0 0 0 0 15 18 1 0 0 0 0 M END > DB01004 > drugbank > NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1 > InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17) > InChIKey=IRSCQMHQWWYFCW-UHFFFAOYSA-N > 7 > 24.154164573887854 > 1 > 4 > 255.096753929 > 0 > C9H13N5O4 > 0 > 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-1H-purin-6-one > -1.83 > -2.179902508666667 > -1.35 > 255.2306 > 0 > 2 > 0 > 14.298583858244307 > 10.159807017663518 > 1.7601277428844484 > 134.99 > 61.029300000000006 > 5 > 1 > 1.15e+01 g/l > gancyclovir > 0 > DB01004 > approved; investigational > Ganciclovir > 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine; GA2; Gancyclovir > Cytovene; Cytovene IV; Vitrasert; Zirgan > Ganciclovir Sodium $$$$